Cascades Between MiRNAs, LncRNAs and the NF-κB Signaling Pathway in Gastric Cancer (Review)

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2021 May 31

PMID 34055068

Citations 10

Authors

Risheng Chen

Mingxiu Yang

Weiguo Huang

Baiyun Wang

Affiliations

Soon will be listed here.

Abstract

Gastric cancer is a common digestive tract malignancy that is mainly treated with surgery combined with perioperative adjuvant chemoradiotherapy and biological targeted therapy. However, the diagnosis rate of early gastric cancer is low and both postoperative recurrence and distant metastasis are thorny problems. Therefore, it is essential to study the pathogenesis of gastric cancer and search for more effective means of treatment. The nuclear factor-κB (NF-κB) signaling pathway has an important role in the occurrence and development of gastric cancer and recent studies have revealed that microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are able to regulate this pathway through a variety of mechanisms. Understanding these interrelated molecular mechanisms is helpful in guiding improvements in gastric cancer treatment. In the present review, the functional associations between miRNAs, lncRNAs and the NF-κB signaling pathway in the occurrence, development and prognosis of gastric cancer were discussed. It was concluded that miRNAs and lncRNAs have complex relations with the NF-κB signaling pathway in gastric cancer. miRNAs/target genes/NF-κB/target proteins, signaling molecules/NF-κB/miRNAs/target genes, lncRNAs/miRNAs/NF-κB/genes or mRNAs, lncRNAs/target genes/NF-Κb/target proteins, and lncRNAs/NF-κB/target proteins cascades are all important factors in the occurrence and development of gastric cancer.

Citing Articles

Development of a disulfidptosis-related lncRNA prognostic signature for enhanced prognostic assessment and therapeutic strategies in lung squamous cell carcinoma.

Zhu A, Zong Y, Gao X Sci Rep. 2024; 14(1):17804.

PMID: 39090162 PMC: 11294474. DOI: 10.1038/s41598-024-68423-6.

Bibliometric and visualized analysis of global research on microRNAs in gastric cancer: from 2013 to 2023.

Wang X, Wang C, Han W, Ma C, Sun J, Wang T Front Oncol. 2024; 14:1374743.

PMID: 38800413 PMC: 11116657. DOI: 10.3389/fonc.2024.1374743.

lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways.

Saleh R, Al-Ouqaili M, Ali E, Alhajlah S, Kareem A, Shakir M Med Oncol. 2024; 41(2):52.

PMID: 38195957 DOI: 10.1007/s12032-023-02263-8.

Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer.

Li Q, Yin L World J Clin Oncol. 2023; 14(10):373-399.

PMID: 37970110 PMC: 10631345. DOI: 10.5306/wjco.v14.i10.373.

Development and verification of a newly established cuproptosis-associated lncRNA model for predicting overall survival in uterine corpus endometrial carcinoma.

Hu P, Wang Y, Chen X, Zhao L, Qi C, Jiang G Transl Cancer Res. 2023; 12(8):1963-1979.

PMID: 37701111 PMC: 10493807. DOI: 10.21037/tcr-23-61.

References

Yang S, Huang C, Li X, Yu M, He Y, Li J . miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology. 2013; 306:162-8. DOI: 10.1016/j.tox.2013.02.014. View

Dong H, Lei J, Ding L, Wen Y, Ju H, Zhang X . MicroRNA: function, detection, and bioanalysis. Chem Rev. 2013; 113(8):6207-33. DOI: 10.1021/cr300362f. View

Zhang J, Chen Z, Chen D, Tian X, Wang C, Zhou Z . LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis. Oncogene. 2018; 37(20):2660-2675. PMC: 5955863. DOI: 10.1038/s41388-018-0162-y. View

Wu W, Yang J, Feng X, Wang H, Ye S, Yang P . MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer. 2013; 12:30. PMC: 3653742. DOI: 10.1186/1476-4598-12-30. View

Soto G, Naranjo Gonzalez M, Calero F . Intravenous lidocaine infusion. Rev Esp Anestesiol Reanim (Engl Ed). 2018; 65(5):269-274. DOI: 10.1016/j.redar.2018.01.004. View

Shin V, Jin H, Ng E, Cheng A, Chong W, Wong C . NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis. 2010; 32(2):240-5. DOI: 10.1093/carcin/bgq240. View

Crone S, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund A . microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer. 2012; 11:71. PMC: 3515505. DOI: 10.1186/1476-4598-11-71. View

Koyama S . Differential expression of intracellular apoptotic signaling molecules in tumor and tumor-infiltrating lymphocytes during development of invasion and/or metastasis of gastric carcinoma. Dig Dis Sci. 2004; 48(12):2290-300. DOI: 10.1023/b:ddas.0000007865.96569.9a. View

Majeed W, Iftikhar A, Khaliq T, Aslam B, Muzaffar H, Atta K . Gastric Carcinoma: Recent Trends in Diagnostic Biomarkers and Molecular Targeted Therapies. Asian Pac J Cancer Prev. 2016; 17(7):3053-60. View

10.

Peng L, Yuan X, Jiang B, Tang Z, Li G . LncRNAs: key players and novel insights into cervical cancer. Tumour Biol. 2015; 37(3):2779-88. DOI: 10.1007/s13277-015-4663-9. View

11.

Li N, Wang J, Yu W, Dong K, You F, Si B . MicroRNA‑146a inhibits the inflammatory responses induced by interleukin‑17A during the infection of Helicobacter pylori. Mol Med Rep. 2018; 19(2):1388-1395. DOI: 10.3892/mmr.2018.9725. View

12.

Ma X, Ning S . Shikimic acid promotes estrogen receptor(ER)-positive breast cancer cells proliferation via activation of NF-κB signaling. Toxicol Lett. 2019; 312:65-71. DOI: 10.1016/j.toxlet.2019.04.030. View

13.

Sha M, Ye J, Zhang L, Luan Z, Chen Y, Huang J . Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-κB signaling pathway. Pharmacology. 2014; 93(1-2):39-46. DOI: 10.1159/000357683. View

14.

Yang X, Sun S . Targeting signaling factors for degradation, an emerging mechanism for TRAF functions. Immunol Rev. 2015; 266(1):56-71. PMC: 4473799. DOI: 10.1111/imr.12311. View

15.

Mattiuzzi C, Lippi G . Current Cancer Epidemiology. J Epidemiol Glob Health. 2019; 9(4):217-222. PMC: 7310786. DOI: 10.2991/jegh.k.191008.001. View

16.

Luo Z, Zheng Y, Zhang W . Pleiotropic functions of miR107 in cancer networks. Onco Targets Ther. 2018; 11:4113-4124. PMC: 6054759. DOI: 10.2147/OTT.S151236. View

17.

Ranjbar R, Hesari A, Ghasemi F, Sahebkar A . Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection. J Cell Biochem. 2018; 119(9):7570-7576. DOI: 10.1002/jcb.27067. View

18.

Li X, Zhang Z, Yu M, Li L, Du G, Xiao W . Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). Int J Mol Sci. 2013; 14(8):16226-39. PMC: 3759908. DOI: 10.3390/ijms140816226. View

19.

Yamanaka N, Sasaki N, Tasaki A, Nakashima H, Kubo M, Morisaki T . Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma. Anticancer Res. 2004; 24(2C):1071-5. View

20.

Dastmalchi N, Khojasteh S, Nargesi M, Safaralizadeh R . The correlation between lncRNAs and Helicobacter pylori in gastric cancer. Pathog Dis. 2020; 77(9). DOI: 10.1093/femspd/ftaa004. View